Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Genocea financial update

    Genocea Biosciences Inc.(NASDAQ:GNCA), Cambridge, Mass. Business: Infectious Date announced: 2015-03-17 Note: Genocea raised $6.7 million through the sale of 818,181 shares at $8.25 to cover the overallotment from its …

    Published on 3/23/2015
  • Heat Biologics financial update

    Heat Biologics Inc.(NASDAQ:HTBX), Chapel Hill, N.C. Business: Cancer, Inflammation, Infectious Date announced: 2015-03-16 Note: Heat Biologics raised $1.6 million through the sale of 246,000 shares at $6.50 to cover the…

    Published on 3/23/2015
  • Horizon Pharma financial update

    Horizon Pharma plc(NASDAQ:HZNP), Dublin, Ireland Business: Autoimmune, Inflammation, Neurology Date announced: 2015-03-13 Note: Horizon Pharma raised $50 million through the sale of senior convertible notes following …

    Published on 3/23/2015
  • Inovio Pharmaceuticals Inc, Duke University, Emory University, NIH, University of Massachusetts, University of Pennsylvania financial update

    Inovio Pharmaceuticals Inc. (NASDAQ:INO), Blue Bell, Pa. Duke University, Durham, N.C. Emory University, Atlanta, Ga. National Institutes of Health, Bethesda, Md. University of Massachusetts, Amherst, Mass. University…

    Published on 3/23/2015
  • Kythera financial update

    Kythera Biopharmaceuticals Inc.(NASDAQ:KYTH), Calabasas, Calif. Business: Dermatology Date announced: 2015-03-16 Note: Kythera raised $18.8 million through the sale of 390,625 shares at $48 to cover the overallotment …

    Published on 3/23/2015
  • Nanotherapeutics financial update

    Nanotherapeutics Inc., Alachua, Fla. Business: Drug delivery, Musculoskeletal Date announced: 2015-03-17 Note: Nanotherapeutics secured a $28.5 million debt facility from White Oak Global Advisors.

    Published on 3/23/2015
  • Signal Genetics financial update

    Signal Genetics Inc.(NASDAQ:SGNL), New York, N.Y. Business: Pharmacogenetics, Diagnostic Date announced: 2015-03-02 Note: Signal Genetics raised $1.3 million through the sale of 482,142 shares at $2.80 to cover the …

    Published on 3/23/2015
  • Summit Therapeutics financial update

    Summit Therapeutics plc(LSE:SUMM; NASDAQ:SMMT), Abingdon, U.K. Business: Musculoskeletal, Infectious Date announced: 2015-03-18 Note: Summit raised $5.1 million through the sale of 517,500 ADSs at $9.90 to cover the …

    Published on 3/23/2015
  • Tetraphase financial update

    Tetraphase Pharmaceuticals Inc.(NASDAQ:TTPH), Watertown, Mass. Business: Infectious Date announced: 2015-03-17 Note: Tetraphase raised $22.6 million through the sale of 645,000 shares at $35 to cover the overallotment …

    Published on 3/23/2015
  • Vivo Capital financial update

    Vivo Capital, Palo Alto, Calif. Business: Finance Date announced: 2015-03-17 Note: Vivo Capital closed its Vivo Capital Fund VIII at $750 million. The firm plans to invest the fund in late-stage pharma and medical …

    Published on 3/23/2015
  • Admedus proposes rights offering

    Admedus Ltd.(ASX:AHZ), Perth, Australia Business: Transplant, Infectious Date announced: 2015-03-18 Type: Rights offering To be raised: Up to A$16.1 million ($12.3 million) Shares: 230.6 million Price: A$0.07 Shares …

    Published on 3/23/2015
  • Biodel proposes follow-on

    Biodel Inc.(NASDAQ:BIOD), Danbury, Conn. Business: Endocrine/Metabolic, Drug delivery Date announced: 2015-03-19 Type: Follow-on To be raised: Up to $30 million Shares: TBD Price Prior: $1.38 Underwriters: William Blair…

    Published on 3/23/2015
  • Cidara Therapeutics proposes IPO

    Cidara Therapeutics Inc., San Diego, Calif. Business: Infectious Date announced: 2015-03-13 Type: IPO To be raised: Up to $69 million Shares: TBD Price: TBD Underwriters: Jefferies; Leerink Partners; Wedbush; Needham; …

    Published on 3/23/2015
  • OxiGene proposes direct public offering

    OxiGene Inc.(NASDAQ:OXGN), South San Francisco, Calif. Business: Cancer, Ophthalmic Date announced: 2015-03-20 Type: Direct public offering To be raised: Up to $10 million Units: TBD Price: $1.71 (unit) Shares …

    Published on 3/23/2015
  • Wilex proposes rights offering

    Wilex AG(Xetra:WL6), Munich, Germany Business: Cancer Date announced: 2015-03-18 Type: Rights offering To be raised: Up to EUR4.2 million ($4.4 million) Shares: 1.5 million Price: EUR2.80 Shares outstanding prior: 7.8 …

    Published on 3/23/2015
  • ZS Pharma proposes follow-on

    ZS Pharma Inc.(NASDAQ:ZSPH), Coppell, Texas Business: Renal, Cardiovascular, Hepatic Date announced: 2015-03-13 Type: Follow-on To be raised: $150 million Shares: TBD Price Prior: $47.24 Underwriters: JPMorgan; Credit …

    Published on 3/23/2015
  • Cellectis S.A amends follow-on

    Cellectis S.A. (Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date announced: 2015-03-10 Type: Follow-on To be raised: TBD Shares: TBD Price prior: EUR12.53 Underwriters: BofA Merrill Lynch; Piper…

    Published on 3/16/2015
  • OSE Pharma amends IPO

    Orphan Synergy Europe-Pharma S.A., Paris, France Business: Cancer, Pulmonary Date announced: 2015-03-09 Type: IPO To be raised: EUR18.4 million ($19.9 million) Shares: 1.7 million Price: EUR8-EUR10.80 Overallotment: 293…

    Published on 3/16/2015
  • SteadyMed amends IPO

    SteadyMed Ltd., Rehovot, Israel Business: Drug delivery Date announced: 2015-03-09 Type: IPO To be raised: Up to $59.5 million Shares: 4.3 million Price: $12-$14 Underwriters: Wells Fargo; RBC Capital Markets; JMP …

    Published on 3/16/2015
  • Valeritas amends IPO

    Valeritas Inc., Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Date announced: 2015-03-09 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: Piper Jaffray; Leerink …

    Published on 3/16/2015
  • Xbiotech amends IPO

    XBiotech Inc., Austin, Texas Business: Antibodies Date announced: 2015-03-10 Type: IPO To be raised: Up to $80 million Shares: 4 million Price: $18-$20 Underwriter: WR Hambrecht Note: XBiotech amended its IPO and now …

    Published on 3/16/2015
  • Addex Therapeutics Ltd completes private placement

    Addex Therapeutics Ltd. (SIX:ADXN), Geneva, Switzerland Business: Neurology, Autoimmune, Endocrine/Metabolic Date completed: 2015-03-09 Type: Private placement Raised: CHF2.8 million ($2.8 million) Shares: 921,667 Price…

    Published on 3/16/2015
  • ADMA Biologics Inc completes follow-on

    ADMA Biologics Inc. (NASDAQ:ADMA), Ramsey, N.J. Business: Hematology, Infectious Date completed: 2015-03-13 Type: Follow-on Raised: $9.8 million Shares: 1.2 million Price: $8 Shares after offering: 10.5 million …

    Published on 3/16/2015
  • Allergen Research completes venture financing

    Allergen Research Corp., San Mateo, Calif. Business: Inflammation Date completed: 2015-03-12 Type: Venture financing Raised: $80 million Investors: Foresite Capital; Longitude Capital Management; Fidelity; Aisling …

    Published on 3/16/2015
  • AmpliPhi Biosciences Corp completes private placement of common stock and warrants

    AmpliPhi Biosciences Corp. (OTCBB:APHB), Richmond, Va. Business: Infectious Date completed: 2015-03-10 Type: Private placement of common stock and warrants Raised: $13 million Shares: 78.8 million Price: $0.17 Shares …

    Published on 3/16/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993